1. CYT003, a TLR9 agonist, in persistent allergic asthma – a randomized placebo‐controlled Phase 2b study. Issue 9 (22nd June 2015) Authors: Casale, T. B.; Cole, J.; Beck, E.; Vogelmeier, C. F.; Willers, J.; Lassen, C.; Hammann‐Haenni, A.; Trokan, L.; Saudan, P.; Wechsler, M. E. Journal: Allergy Issue: Volume 70:Issue 9(2015:Sep.) Page Start: 1160 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. SAT0151 Safety Profile of BOW015, A Biosimilar Infliximab, In Healthy Subjects and Patients with Active Rheumatoid Arthritis. (9th June 2015) Authors: Kay, J.; Lassen, C.; Trokan, L.; Wyand, M. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 706 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗